Estrogen has a variety of genetic and epigenetic changes in the occurrence and development of thyroid cancer, in which activation of phosphatidylinositol-3 kinase (PI3K)/AKT signal pathway and mitogen-activated protein kinases (MAPK) signal pathway due to mutations are critical in cancer progression. The gene discussed is AKT1; the disease is thyroid cancer.